Safety Study of Herpes Simplex Vaccine in HSV Seronegative and Seropositive Females Between 10 and 17 Years Old
Clinical trial NCT00224484 · COMPLETED
Trial details
- NCT number
- NCT00224484
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-04-07
- Primary completion
- 2007-07-24
- Enrollment
- 5960
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.